BD交易繁荣背后,结构性矛盾待解

第一财经
Aug 19

在创新驱动发展战略指引下,我国生物医药产业进入从药品仿制迈向源头创新的转型攻坚期。本土创新药企培育出一批具有全球竞争力的优质研发资产,凭借创新药业务拓展(BD)登上国际舞台。BD交易作为资源整合的关键路径,其井喷式增长态势标志着我国创新药产业化升级的阶段性成果,但需警惕繁荣背后折射的深层问题。创新药BD交易井喷式增长我国BD交易呈现井喷式增长。2024年全年,我国医药BD交易总额达635亿美元,...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10